liver background image

Liver ultrasound

The ultimate solution for liver assessment

Blue and green graph of the liver ultrasound machine properties
It’s no secret that liver disease is a growing health concern.

Globally, liver disease accounts for around 2 million deaths per year, with around 1 million of those due to cirrhosis and 1 million due to viral hepatitis and hepatocellular carcinoma. Unhealthy lifestyle choices like obesity, alcohol and drug use are the root causes of the disease and in most cases, liver disease can be prevented1.​

For decades, liver biopsy has been the conventional method for disease assessment, and more recently MR Proton Density Fat Fraction (MR-PDFF) has been added to measure liver fat. This method, however, presents several patient barriers including the pain of biopsy, access to MR imaging, high cost and long wait times.

This is where Philips comes in. Thanks to innovations to Philips EPIQ & Affiniti ultrasound systems there is now a comprehensive solution to support the assessment, treatment and monitoring of liver disease, with four key features working together in one effective tool.
Video explaining Philips' liver ultrasound machines
Quantitative icon

Quantitative parameters for assessment of steatosis

with Philips Liver Fat Quantification (LFQ) tools.
Acquisition icon

Easy, fast and robust acquisition

with ElastQ imaging.*
Pain icon

29% to 85% reduced pain and fatigue

from scanning with the C5-1 transducer compared to conventional transducers.
*Side-by-side view of unique imaging confidence and stiffness maps helps reduce workflow steps and allows for simultaneous map correlation during acquisition and measurement phases.
The widespread use of this technology in a general population could be helpful in screening for advanced chronic liver disease, especially considering that a complete study can be done in under three minutes using a non-invasive method for chronic liver disease.”

Richard G. Barr, MD, PhD 

President, Radiology Consultant, Inc. (Youngstown, Ohio)  Medical Director, Southwoods Imaging 

Manage liver patients with confidence

Elevate confidence in liver diagnosis with the latest general imaging ultrasound advances from Philips.
Expert perspectives PDF

Diagnostic confidence

Quantifying liver fat with ultrasound

Current standards for diagnosing and measuring non-alcoholic fatty liver disease (NAFLD) – liver biopsy and MRI – are impractical for various reasons. The emerging technique of ultrasound attenuation imaging could be helpful in screening for NAFLD. A leading physician explains how.

Did you know ?

Linked strongly with obesity, it is estimated that
non-alcoholic fatty liver disease affects as many as one billion individuals worldwide. Learn more about liver fat quantification (LFQ) in this Philips white paper. 
Now that there is a quantitative way of measuring liver fat, it will make it a lot easier for us to let the referring physician determine where the patient is quantitatively on the NAFLD spectrum.”

Dr. Richard G. Barr, Southwoods Imaging,

Youngstown, Ohio USA

Easy quantifiable tools to assess liver health

ElastQ and LFQ icon

ElastQ imaging

ElastQ provides a 2D shear wave (2D-SWE) real-time assessment of tissue stiffness that is noninvasive, reproducible, and easy to perform. ElastQ also includes the ability to make retrospective measurements on stored images and includes a confidence map for adequate shear wave propagation display.

ElastPQ imaging

ElastPQ is a point shear wave (pSWE) method of obtaining tissue stiffness values of the liver. Using real-time imaging as a guide, the ROI is placed over the area of interest and tissue stiffness data is acquired in seconds. Multiple samples can be recorded and generated into a liver report.

Attenuation imaging

Attenuation Imaging can measure the amount of fat present in the liver by calculating the attenuation coefficient of sound absorbed  by the liver parenchyma. This method provides quantitative attenuation parameters that can help assist physicians in the management of patients with hepatic steatosis.

HRI imaging

HRI imaging technology compares the relative brightness of the liver parenchyma to the kidney and provide fast, quantifiable liver steatosis information.
Attenuation imaging
Attn with confidence
ElastQ imaging
EPIQ vm elas_q_s with measure

Contrast enhanced liver ultrasound

Contrast enhanced ultrasound icon
Ultrasound contrast agents can transform the role of ultrasound, allowing clinicians to study the enhancement patterns of liver lesions in real time. With Philips ultrasound, contrast enhanced ultrasound is seamlessly integrated into the standard workflow.
EPIQ CM9 contrast SBS liver lesion
EPIQ vm9 mc7 contrast MFI
CEUS image

Image fusion and navigation

Image fusion and navigation icon
Make confident decisions even in challenging diagnostic cases with Philips image fusion and needle navigation capabilities. Streamlined workflow allows clinicians to achieve fast and effective fusion of CT/MR/PET with live ultrasound while needle navigation aids in guiding biopsy of small and difficult-to-access lesions2.

Using Tumor contour, users can plan and target lesions with a semi-automated tool that helps outline a 3D contour around a structure of interest, potentially improving procedure guidance with challenging cases where the lesion may not be easily visualized.
Image fusion with navigation
Scan image

Transducers created to image all body habitus

Transducers for all body types icon
People come in many different shapes and sizes, with PureWave crystal technology you can improve penetration in difficult to scan body types, all while maintaining excellent detail resolution, Doppler sensitivity and contrast enhanced ultrasound (CEUS) performance.

PureWave crystal technology is the biggest breakthrough in piezoelectric transducer material in 40 years and is 85% more efficient than conventional piezoelectric materials, resulting in exceptional performance for all patient body types.


Related products

    EPIQ Elite A new class of premium ultrasound has arrived

    EPIQ Elite  

    • nSIGHT Imaging is a totally different approach to ultrasound
    • PureWave and xMATRIX for leading-edge ultrasound transducer technology
    • 24" HD MAX Display for the ultimate ultrasound visualization experience
    Affiniti Ultrasound system

    Affiniti 70

    • It understands your every day
    • Designed for balance
    • Workflow meets wow
    Affiniti Ultrasound system

    Affiniti 50

    • Designed for balance
    • Workflow meets wow
    • Performance you can see


1 Asrani et al, Burden of liver disease in the world. Journal ofhepatology, Vol 70, Issue 1, 2019.)​
2 Kim E, Patel RS, Fischman AM, Nowakowski S, Lookstein RA. CT-Guided Liver Biopsy With Electromagnetic Tracking: Results From a Single-Center Prospective Randomized Controlled Trial. AJR 2014; 203:W715–W723)​

Ultrasound portfolio extensions

Let Philips help you leverage the full potential of ultrasound over a wide range of clinical care areas with a comprehensive portfolio of performance-driven products, services and knowledge.
Cardiovascular icon
General imaging icon
General imaging
Point of care icon
Point of care
Refurbished systems icon
Refurbished systems
Education and training icon
Education & training
Ultrasound services icon
Ultrasound services
Transducers icon
Select your area of interest
Contact details

We are always interested in engaging with you.

Let us know how we can help.

Contact details

You are about to visit a Philips global content page

You are about to visit the Philips USA website.

You are about to visit a Philips global content page

You are about to visit the Philips USA website.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.